Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-085693
Filing Date
2021-06-25
Accepted
2021-06-25 16:01:43
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2114556d16_s1.htm S-1/A 102858
2 EXHIBIT 10.11 tm2114556d16_ex10-11.htm EX-10.11 79196
3 EXHIBIT 10.12 tm2114556d16_ex10-12.htm EX-10.12 75950
4 EXHIBIT 10.13 tm2114556d16_ex10-13.htm EX-10.13 85571
  Complete submission text file 0001104659-21-085693.txt   344558
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-256949 | Film No.: 211047646
SIC: 2834 Pharmaceutical Preparations